Events & Presentations

Share this on: Delicious Digg Facebook LinkedIn Twitter What is this?

Chelsea Therapeutics Reports Results of Pivotal Phase III Study 301

Sep 20, 2010 at 8:30 AM ET

Registration is required to listen to this webcast. * Required fields

First Name *	Last Name *
Email *	Title *
Company *	Investor Type *   Individual Investor Equity Analyst (sell-side) Equity Analyst (buy-side) Fixed Income Analyst (sell-side) Fixed Income Analyst (buy-side) Portfolio Manager (Equity) Portfolio Manager (Fixed Income) Broker/Investment Advisor Banker/Financing Source Press/Media Consultant Employee Customer/Client Library/Reference Student Other
Type in number *   This helps Chelsea Therapeutics International, Ltd. prevent automated submissions.

Remember me at this computer so I can skip registration in the future.
I am interested in receiving notifications for upcoming webcasts. **

** An email will be sent to your email address confirming your identity. You will then be given options to sign up for webcast and other alerts.